GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
Revenue excluding sweetbiotix and microbiome modulators won't be anywhere close to the £3m. Likely you say 1 full year with Morepen won't synchronise with the OptiBiotix full year.
Based on one of the forecast slides, I'm expecting close to 1.5m.
Https://www.gloucestershirelive.co.uk/news/health/20p-day-supplement-boosts-brain-9135552
Could Opti cash in on these benefits?
We know the standard royalty % with the US partner is 5% plus another 5% for the MTA partners. I think it's safe to assume that OptiBiotix royalty with DSM Firmenich is 5%.
I don't think it'll be too far off that figure
The actual text was > 100k tonnes and this is for only DSM Firmenich.
The US partner will most likely have similar forecast with any few of the big 11 global MTA partners signing up for sweetbiotix. I think this is in the early stages of a major re-rate of the sp.
Original US sweetbiotix deal -
OptiBiotix will receive a modest six-figure payment from the Company on signing the agreement and at 12 monthly intervals until product launch. Additional similar payments will be due on product launch plus royalties on all future product sales.
Does this mean another payment on the launch of the first sweetbiotix product?
Https://www.symbiopharm.de/produkte/symbiolife-praezisionsprobiotika/symbiolife-cholesterin-control